Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > A project coordinated by VTT turns plant cells into medical factories

Abstract:
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner. The methods based on plant biotechnology are an alternative to chemical synthesis. By controlling the cell metabolism of a ‘green factory', i.e. a living plant cell, it is possible to affect the production of desired high-value compounds. This kind of metabolic engineering also stimulates the cells towards producing completely new compounds.

A project coordinated by VTT turns plant cells into medical factories

Finland | Posted on September 19th, 2008

Plants generate valuable secondary metabolic compounds, which can be used as pharmaceuticals. Most of these compounds are so complex that their chemical synthesis is not economically feasible. This is why biotechnology opens up a whole new avenue of possibilities. The SmartCell project will focus on terpene compounds, which are valuable for the pharmaceutical industry. These compounds for example are used in the treatment of cancer and malaria. The expertise and technology created during the project can be applied to a considerable extent in developing the biotechnological production of other compound groups in plants and plant cells.

"The opportunities offered by plant biotechnology could be much more extensively exploited in the pharmaceutical industry. The latest research methods can be used to intensify the production of valuable agents in plant cells; in a manner of speaking, plant cells could become real ‘green factories'," says project coordinator, Chief Research Scientist Kirsi-Marja Oksman-Caldentey of VTT.

The SmartCell project brings together research partners from fourteen leading European research institutes and universities as well as three small and medium-sized and two major industrial enterprises. In addition to VTT, the project participants include e.g. VIB (Belgium), Leiden University (the Netherlands), Lleida University (Spain) and Fraunhofer IME Aachen, (Germany). The project's total budget is EUR 8.5 million, of which the EU's contribution is EUR 6 million. The contractual negotiations will soon be concluded, and the project will start in January 2009.

####

About VTT Technical Research Centre
VTT Technical Research Centre of Finland the biggest multitechnological applied research organisation in Northern Europe. VTT provides high-end technology solutions and innovation services. From its wide knowledge base, VTT can combine different technologies, create new innovations and a substantial range of world class technologies and applied research services thus improving its clients' competitiveness and competence. Through its international scientific and technology network, VTT can produce information, upgrade technology knowledge, create business intelligence and value added to its stakeholders. VTT is a non-profit-making research organisation.

For more information, please click here

Contacts:
VTT Technical Research Centre of Finland
Chief Research Scientist
Docent Kirsi-Marja Oksman-Caldentey
tel. +358 (0)20 722 4459

Copyright © VTT Technical Research Centre

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Discoveries

Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project